Probi AB (PROB) - Financial and Strategic SWOT Analysis Review

Probi AB (PROB) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH82167FSA
  • |
  • Pages: 55
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Probi AB (PROB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Probi AB (Probi) is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and immune system. It distributes its products to leading food, health-product and pharmaceutical companies in the functional food and consumer healthcare segments. Probi markets its products through four different platforms: Probi Premium, Probi Select, Probi LiveBac and Probi Bio-tract. The company has operational presence in Sweden, Rest of Europe, North America and Rest of world. Probi is headquartered in Lund, Sweden.

Probi AB Key Recent Developments

Jul 19,2018: Probi announces resignation of Jorn Andreas as CFO

Apr 11,2018: Probi enters the bone health area-a new area for probiotics

Mar 14,2018: Probi Appoints Ole Sogaard Andersen As Interim CEO

Feb 06,2018: Probi's largest clinical trial confirms the immune enhancing impact of Probi Defendum and sheds new light on the mechanism

Jan 25,2018: Probi: Q4-2017 Year-End Report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Probi AB-Key Facts 6

Probi AB-Key Employees 7

Probi AB-Key Employee Biographies 8

Probi AB-Major Products and Services 9

Probi AB-History 10

Probi AB-Company Statement 13

Probi AB-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

Company Overview 16

Probi AB-Business Description 17

Business Segment: Consumer Healthcare Segment 17

Overview 17

Performance 17

Business Segment: Functional Food Segment 17

Overview 17

Performance 17

Geographical Segment: North America 17

Performance 17

Geographical Segment: Rest of Europe 17

Performance 17

Geographical Segment: Rest of the World 18

Performance 18

Geographical Segment: Sweden 18

Performance 18

Probi AB-SWOT Analysis 19

SWOT Analysis-Overview 19

Probi AB-Strengths 19

Probi AB-Weaknesses 20

Probi AB-Opportunities 21

Probi AB-Threats 22

Probi AB-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Probi AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Probi AB, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Apr 11, 2018: Probi enters the bone health area-a new area for probiotics 34

Feb 06, 2018: Probi's largest clinical trial confirms the immune enhancing impact of Probi Defendum and sheds new light on the mechanism 35

Jan 25, 2018: Probi: Q4-2017 Year-End Report 36

Oct 25, 2017: Probi: Interim report Q1-Q3 2017 41

Sep 11, 2017: New clinical study shows that Probi's probiotics support the immune system and may delay the onset of gluten intolerance in children 45

May 04, 2017: Probi continues on its successful growth path 46

Feb 14, 2017: Probi appoints Jorn Andreas as new CFO 49

Jan 10, 2017: Probi-Strong Growth in net Sales and Operating Profit in the Fourth Quarter 50

Section 6-Appendix 51

Methodology 51

Ratio Definitions 51

About GlobalData 55

Contact Us 55

Disclaimer 55

List of Figures

Probi AB, Performance Chart (2013-2017) 28

Probi AB, Ratio Charts 30

Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Probi AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

List of Tables

Probi AB, Key Facts 6

Probi AB, Key Employees 7

Probi AB, Key Employee Biographies 8

Probi AB, Major Products and Services 9

Probi AB, History 10

Probi AB, Subsidiaries 15

Probi AB, Key Competitors 23

Probi AB, Ratios based on current share price 24

Probi AB, Annual Ratios 25

Probi AB, Annual Ratios (Cont...1) 26

Probi AB, Annual Ratios (Cont...2) 27

Probi AB, Interim Ratios 29

Probi AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Probi AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Probi AB, Recent Deals Summary 33

Currency Codes 51

Capital Market Ratios 51

Equity Ratios 52

Profitability Ratios 52

Cost Ratios 53

Liquidity Ratios 53

Leverage Ratios 54

Efficiency Ratios 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Yakult Honsha Co Ltd

Meda AB

Lallemand Inc

Danone SA

Danisco A/S

Chr. Hansen Holding A/S

Camurus AB

Probi AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8908
Site License
USD 250 INR 17815
Corporate User License
USD 375 INR 26723



We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]